Medical Collagen Market Report 2025 (Global Edition)

Global Medical Collagen Market Report 2025 Market Size Split by Source (Bovine, Porcine, Others), by Product (Gelatine, Hydrolyzed Collagen, Native Collagen, Others), by Application (Wound Care, Bone ...

Medical Collagen Market Report Description

We have various report editions of Medical Collagen Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Impact of Tariff Trumph on Pharmaceuticals Industry

The reintroduction of tariffs under President Trump’s “Liberation Day Tariffs” in April 2025 has created significant disruption in global pharmaceutical trade. These tariffs, ranging from 10% to 46%, specifically target pharmaceutical products, APIs (active pharmaceutical ingredients), medical packaging, and machinery from key manufacturers in China and India. This has led to increased production costs, supply chain delays, and regulatory challenges for U.S.-based pharmaceutical companies.

The tariffs have particularly impacted generic drug manufacturers, who rely heavily on APIs from China and India. Biopharmaceuticals and vaccines are also feeling the pressure, with tariffs on critical materials like bioproduction media and cold-chain packaging raising costs by up to 25%. Similarly, contract manufacturing organizations (CMOs) are grappling with the need to identify new suppliers and adjust production plans to mitigate rising costs.

Foreign governments, including the European Union, have retaliated with tariffs on U.S. pharmaceutical exports, further complicating global trade. Clinical trials are also impacted, as tariffs on drugs and diagnostic kits delay trial timelines.

Market research is increasingly crucial for navigating these challenges. By providing real-time data on API pricing, supplier reliability, and tariff impact, pharmaceutical firms can make informed decisions on sourcing, compliance, and investment strategies. This data-driven approach helps mitigate risks, optimize supply chains, and identify alternative manufacturing hubs to offset tariff-related disruptions.

Overall, market research is essential for pharmaceutical companies to adapt to the new tariff landscape, enabling them to maintain competitive advantage and navigate global trade dynamics effectively.

Medical Collagen Market Insights Video

Competitive Landscape of the Medical Collagen Market

The competitive landscape of the medical collagen market is marked by a diverse range of companies, from well-established biomedical firms to specialized biotech innovators. Leading market players are investing heavily in R&D projects to create more sustainable, effective collagen-based solutions, such as plant-based or recombinant collagen alternatives, which can appeal to both ethical and quality-conscious consumers.

In June 2023, Revive Collagen extended internationally with Saks Fifth Avenue. The brand will launch ready-to-drink collagen products, such as marine collagen supplements infused with beauty components and essential vitamins. (Source: https://cosmeticsbusiness.com/revive-collagen-announces-international-expansion-with-saks-fifth-avenue-launch-209594) In April 2022, Rousselot announced the availability of GMP-grade GelMA for medical applications. This strategy will increase consumer satisfaction with its collagen-based products globally. (Source: https://www.rousselot.com/biomedical/media/news/rousselotr-biomedical-announces-the-worlds-first-gmp-grade-gelma) In January 2021, GELITA launched Bioactive Collagen Peptides (BCP®) under the IMMUPEPT™ brand. This product was created to provide optimal stimulation of connective tissues and collagen-rich fibroblasts to strengthen the bone immune system. (Source: https://www.nutritioninsight.com/news/gelita-expands-to-immunity-sector-with-keratinocyte-rich-collagen-peptide-launch.html)

Top Companies Market Share in Medical Collagen Industry: (In no particular order of Rank)

• Collagen Solutions PLC (U.K.)
• Harbin Kelin Biotech Group (China)
• Evolva Holding S.A. (Switzerland)
• Nitta Gelatin Inc. (Japan)
• Gelita AG (Germany)
• Integra LifeSciences Corporation (U.S.)
• Hughes Systique Corporation (U.S.)
• Medtronic PLC (Ireland)
• DSM Biomedical (Netherlands)
• Trevira GmbH (Germany)
• CollPlant Biotechnologies Ltd. (Israel)
• Symatese (France)
• Stryker Corporation (U.S.)
• Royal DSM N.V. (Netherlands)
• Advanced BioMatrix Inc. (U.S.)
• Rousselot BV (Netherlands)
• EnColl Corporation (U.S.)
• Botiss Biomaterials GmbH (Germany)
• Shenzhen Taike Biotechnology Co.
• Ltd. (China)
• KYERON BV (Netherlands)
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Medical Collagen Market

Which Region Dominates the Medical Collagen Market in 2024?

According to Cognitive Market Research, North America currently dominates the medical collagen market due to its modern healthcare infrastructure, higher healthcare spending, and the strong presence of key market players. This region also has a high prevalence of chronic conditions, such as diabetes and osteoarthritis, which increase the demand for collagen-based wound care and orthopaedic solutions. The growing focus on cosmetic procedures, including anti-ageing treatments and dermal fillers, further supports collagen product demand in the aesthetic market.

Which Region is Expanding at the Fastest CAGR?

Asia Pacific stands out as the fastest-growing region in the global medical collagen market, owing to the elevating healthcare investments, rapid urbanization, and growing awareness of regenerative medicine across countries like China, Japan, and South Korea. The rising elderly population in the region, combined with a higher incidence of chronic diseases requiring wound care and orthopaedic treatments, fuels market demand for collagen-based products. Besides, a surge in cosmetic procedures and skincare awareness in countries like India and China further accelerates market expansion.

The current report Scope analyzes Medical Collagen Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

North America Medical Collagen Market Analysis

According to Cognitive Market Research, the global medical collagen market size was estimated at USD 625.6 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 250.2 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031.

• According to Cognitive Market Research, the U.S. had a major share in the medical collagen market with a market size of USD 197.4 million in 2024 and is projected to grow at a CAGR of 5% in the forecast period. In the U.S., the medical collagen market is primarily driven by the growing demand for regenerative medicine and the increasing use of collagen in wound care and orthopaedic treatments.
• The Canadian medical collagen market had a market share of USD 30 million in 2024 and is projected to grow at a CAGR of 6% over the forecast period. The higher adoption of modern surgical procedures, along with a focus on minimally invasive options, is boosting the use of collagen-based products in medical applications in Canada.
• The Mexico medical collagen market is projected to witness growth at a CAGR of 5.7% in the forecast period, with a market size of USD 22.8 million in 2024.

Europe Medical Collagen Market Analysis

According to Cognitive Market Research, the global medical collagen market size was estimated at USD 625.6 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 187.7 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2031.

• The United Kingdom medical collagen market had a market share of USD 31.5 million in 2024 and is projected to grow at a CAGR of 6.3% over the forecast period. The U.K. market for medical collagen is growing due to the rising use of collagen in aesthetic treatments, such as dermal fillers and anti-ageing products, along with the growth in orthopaedic applications.
• The France medical collagen market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD 17.3 million in 2024.
• According to Cognitive Market Research, the German medical collagen market size was valued at USD 37.2 million in 2024 and is projected to grow at a CAGR of 5.7% over the forecast period. The growing acceptance of collagen in medical applications, especially in wound care and surgical procedures, further propels the market in Germany.
• The Italy medical collagen market is projected to witness growth at a CAGR of 4.9% within the forecast period, with a market size of USD 16.1 million in 2024.
• The Russian medical collagen market is projected to witness growth at a CAGR of 4.5% during the forecast period, with a market size of USD 29.1 million in 2024.
• The Spain medical collagen market is projected to witness growth at a CAGR of 4.6% during the forecast period, with a market size of USD 15.4 million in 2024.
• The Luxembourg medical collagen market is projected to witness growth at a CAGR of 5.6% during the forecast period, with a market size of USD 5.8 million in 2024.
• The Portugal medical collagen market is projected to witness growth at a CAGR of 5.3% during the forecast period, with a market size of USD 3.9 million in 2024.
• The Greece medical collagen market is projected to witness growth at a CAGR of 5.8% during the forecast period, with a market size of USD 2.3 million in 2024.
• The Rest of the European medical collagen market is projected to witness growth at a CAGR of 4.2% in the forecast period, with a market size of USD 29.1 million in 2024.

Asia Pacific Medical Collagen Market Analysis

According to Cognitive Market Research, the global medical collagen market size was estimated at USD 625.6 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 143.9 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9% from 2024 to 2031.

• According to Cognitive Market Research, the China medical collagen market size was valued at USD 64.7 million in 2024 and is projected to grow at a CAGR of 8.5% over the forecast period. In China, the rapid expansion of the healthcare sector, alongside increasing awareness of medical aesthetics and skincare, is fueling the demand for medical collagen products.
• The Japan medical collagen market is projected to witness growth at a CAGR of 7.5% during the forecast period, with a market size of USD 19.9 million in 2024.
• The India medical collagen market had a market share of USD 17.3 million in 2024 and is projected to grow at a CAGR of 10.8% over the forecast period. In India, the market for medical collagen is experiencing rapid growth due to the expanding healthcare infrastructure and the rising number of chronic diseases that require effective wound care solutions.
• The South Korean medical collagen market is projected to witness growth at a CAGR of 8.1% during the forecast period, with a market size of USD 14.4 million in 2024.
• The Australian medical collagen market is projected to witness growth at a CAGR of 8.7% during the forecast period, with a market size of USD 7.5 million in 2024.
• The South East Asia medical collagen market is projected to witness growth at a CAGR of 10% during the forecast period, with a market size of USD 9.9 million in 2024.
• The Rest of Asia Pacific medical collagen market is projected to witness growth at a CAGR of 8.8% in the forecast period, with a market size of USD 10.2 million in 2024.

South America Medical Collagen Market Analysis

According to Cognitive Market Research, the global medical collagen market size was estimated at USD 625.6 Million, out of which Latin America held the market share of around 5% of the global revenue with a market size of USD 31.3 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.4% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil medical collagen market size was valued at USD 13.4 million in 2024 and is likely to grow at a CAGR of 7% in the forecast period. In Brazil, the medical collagen industry is expanding due to the rising popularity of cosmetic treatments, such as dermal fillers and collagen injections, in the beauty and aesthetics sectors.
• Argentina medical collagen market had a market share of USD 5.3 million in 2024 and is projected to grow at a CAGR of 7.3% in the forecast period. Argentina is witnessing growth in the medical collagen market due to the increasing demand for skin and tissue regeneration products, particularly in the cosmetic and wound care industries.
• Colombia medical collagen market is projected to witness growth at a CAGR of 6.2% over the forecast period, with a market size of USD 2.8 million in 2024.
• Peru medical collagen market is projected to witness growth at a CAGR of 6.6% during the forecast period, with a market size of USD 2.6 million in 2024.
• Chile medical collagen market is projected to witness growth at a CAGR of 6.7% in the forecast period, with a market size of USD 2.3 million in 2024.
• The Rest of the Latin American medical collagen market is projected to witness growth at a CAGR of 5.5% over the forecast period, with a market size of USD 5 million in 2024.

Middle East Medical Collagen Market Analysis

According to Cognitive Market Research, the global medical collagen market size was estimated at USD 625.6 Million, out of which the Middle East & Africa held the major market share of around 2% of the global revenue with a market size of USD 12.5 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.7% from 2024 to 2031.

• The GCC Countries medical collagen market is projected to witness growth at a CAGR of 7.5% during the forecast period, with a market size of USD 5.4 million in 2024. The GCC countries, including Saudi Arabia and the UAE, are experiencing rapid growth in the medical collagen market due to a rising number of cosmetic surgeries and an increasing demand for aesthetic treatments.
• The Egypt medical collagen market is projected to witness growth at a CAGR of 7% during the forecast period, with a market size of USD 1.3 million in 2024.
• The South Africa medical collagen market is projected to witness growth at a CAGR of 7.7% during the forecast period, with a market size of USD 2 million in 2024. In South Africa, the medical collagen market is benefiting from a rising healthcare demand due to the increasing prevalence of chronic conditions and the growing interest in cosmetic treatments.
• The Turkey medical collagen market is projected to witness growth at a CAGR of 6.2% during the forecast period, with a market size of USD 1.1 million in 2024.
• The Nigeria medical collagen market is projected to witness growth at a CAGR of 5.8% during the forecast period, with a market size of USD 1.3 million in 2024.
• The Rest of the MEA medical collagen market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 1.5 million in 2024.

Medical Collagen Market Analysis

Medical Collagen Market Source Segment Analysis

According to Cognitive Market Research, the bovine source segment leads the medical collagen market due to its wide availability, cost-effectiveness, and compatibility with the human body for various medical applications. Bovine collagen is derived from cow hides and bones, providing a high yield of collagen that can be processed for applications in wound care, orthopaedic treatments, and cosmetic products.

The porcine source is the fastest-growing category in the medical collagen market, owing to increasing demand for high-purity collagen and fewer disease transmission concerns compared to other sources. Porcine collagen, derived from pig tissues, has shown strong potential in tissue engineering and regenerative medicine due to its biochemical properties and lower immunogenicity.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Medical Collagen Industry. Request a Free Sample PDF!

Medical Collagen Market Product Segment Analysis

According to Cognitive Market Research, gelatine holds a dominant position in the medical collagen market due to its versatility, biocompatibility, and widespread use across various medical applications. Gelatine, which is made from partially hydrolyzed collagen, is a flexible and stable material that can be used in wound dressings, medication delivery systems, and tissue engineering. Its ability to promote cell adhesion and support wound healing makes it a preferred choice in regenerative medicine.

Native collagen is a rapidly developing segment in the medical collagen market, mainly due to its purity, minimal processing, and structural integrity that closely resembles natural human collagen. Unlike hydrolyzed forms, native collagen maintains its triple-helix structure, which enhances its effectiveness in applications requiring precise tissue compatibility, such as in specialized wound care, cartilage repair, and cosmetic injectables.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Medical Collagen Application Segment Analysis

Medical Collagen Market Application Segment Analysis

According to Cognitive Market Research, the wound care segment holds the majority share in the medical collagen market due to the key role collagen plays in tissue regeneration and healing. Collagen-based products, such as dressings, gels, and sponges, are widely used to treat chronic and acute wounds, including burns, diabetic ulcers, and surgical wounds. Collagen promotes faster healing by stimulating cell growth and tissue repair, which makes it a key choice for wound care professionals.

Cartilage repair is a rapidly growing application segment in the medical collagen market, largely due to the increasing demand for regenerative treatments for joint-related issues and sports injuries. Due to its structural qualities, collagen is a strong scaffold for promoting cartilage regeneration and boosting cell proliferation in damaged areas. As more people seek alternatives to joint replacement surgeries, collagen-based solutions offer a promising non-invasive approach to cartilage repair.

• Wound Care
• Bone Grafts
• Tissue Scaffolds
• Cartilage Repair
• Haemostats
• Diagnostics
• Vascular Grafts
• Others

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion